PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The antihypertensive effect of Amlodipine/Valsartan combination has been evaluated in
worldwide populations including Asian patients. The study primarily aims to evaluate the
effectiveness of Amlodipine/Valsartan combination in patients with essential hypertension in
Taiwan using a prospective, open-label, non-randomized approach.
The study also wants to investigate the safety of Amlodipine/Valsartan combination during the
6-week treatment period.
Phase:
Phase 4
Details
Lead Sponsor:
TSH Biopharm Corporation Limited
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Valsartan